# Immune Monitoring in Metastatic Melanoma

> **NCT04158544** · — · UNKNOWN · sponsor: **University of Regensburg** · enrollment: 100 (estimated)

## Conditions studied

- Metastatic Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04158544
- **Lead sponsor:** University of Regensburg
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08-01
- **Primary completion:** 2020-07-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04158544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04158544, "Immune Monitoring in Metastatic Melanoma". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04158544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*